SEC Tracker
Get the app

Jazz Pharmaceuticals JAZZ

Renee D Gala (President & CEO) sold 1,000 Jazz at $225.37, worth $225K, under a 10b5-1 plan

Form
4
Filed
Importance
Routine
  1. Sold 1,000 shares at $225.37
  2. Owned 140,394 shares
  3. Transaction date: Nov 3, 2026

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Jazz Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Corcept Therapeutics CORT public float $6.1B, Jun 30, 2025
  2. Repligen RGEN public float $6.0B, Jun 30, 2025
  3. Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
  4. Revolution Medicines RVMD public float $6.7B, Jun 30, 2025
  5. Madrigal Pharmaceuticals MDGL public float $5.6B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.